PUBLISHER: Coherent Market Insights | PRODUCT CODE: 1608872
PUBLISHER: Coherent Market Insights | PRODUCT CODE: 1608872
Diabetes Care Market, By Product Type (Glucose Monitoring Devices, Insulin Pumps, By Diabetes Type, By End User, By Geography
The diabetes care market is estimated to be valued at USD 31.69 billion in 2024 and is expected to reach USD 56.86 billion by 2031, exhibiting a compound annual growth rate (CAGR) of 8.7% from 2024 to 2031.
| Report Coverage | Report Details | ||
|---|---|---|---|
| Base Year: | 2023 | Market Size in 2024: | 31.69 Bn |
| Historical Data for: | 2019 to 2023 | Forecast Period: | 2024 to 2031 |
| Forecast Period 2024 to 2031 CAGR: | 8.70% | 2031 Value Projection: | 56.86 Bn |
Diabetes is a chronic metabolic disease that affects how the body utilizes glucose. The number of people diagnosed with diabetes has been steadily increasing over the years. In July 2022, according to the International Diabetes Federation, over 537 million adults were living with diabetes in 2021 which is projected to grow to 700 million by 2045. The rising prevalence of the disease has led to an increased demand for diabetes care products and services globally. The diabetes care market covers blood glucose monitoring devices like glucometers, test strips, lancets and monitoring systems, insulin delivery devices like insulin pens, pumps, and injectors, and diabetes management apps and software.
Market Dynamics:
The global diabetes care market growth is driven by the growing diabetes patient pool, increasing awareness about diabetes self-management, advancement of diabetes management technologies, and government initiatives to curb the burden of the disease. However, high device costs, limited medical reimbursement in many countries, and risk of inaccurate readings with some devices restrain the market growth. On the other hand, development of artificial pancreas devices that automatically regulate blood glucose levels, ongoing R&D to develop oral insulin formulations, and islet cell transplantations create lucrative opportunities in the market.
Key Features of the Study:
This report provides in-depth analysis of the global diabetes care market, and provides market size (US$ Bn) and compound annual growth rate (CAGR%) for the forecast period (2024-2031), considering 2023 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global diabetes care market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
Key companies covered as a part of this study include Medtronic, Abbott, Pumps It, Inc., Embecta Corp, Insulet Corporation, Ypsomed AG, Roche AG, Tandem Diabetes Care, Inc., Terumo, Novo Nordisk A/S, SOOIL Developments Co., Ltd, Microtec Medical Ltd, ViCentra B.V., CeQur Corporation, and Dexcom, Inc.
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
The global diabetes care market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global diabetes care market
Market Segmentation
- Product Type Insights (Revenue, USD Bn, 2019 - 2031)
- Glucose Monitoring Devices
- Blood glucose monitoring (BGM)
- Continuous glucose monitoring (CGM)
- Flash glucose monitoring (FGM)
- Insulin Pumps
- Patch pump
- Tethered pump
- Implanted insulin pump
- Others (Insulin Syringes, Pen Needles, etc.)
- Diabetes Type Insights (Revenue, USD Bn, 2019 - 2031)
- Type 2 Diabetes
- Type 1 Diabetes
- Other (Gestational Diabetes, etc.)
- End User Insights (Revenue, USD Bn, 2019 - 2031)
- Hospitals & Clinics
- Homecare Settings
- Ambulatory Care Settings
- Others (Academic and Research Institutes, Clinical Laboratories, etc.)
- Regional Insights (Revenue, USD Bn, 2019 - 2031)
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- South Africa
- North Africa
- Central Africa
- Key Players Insights
- Medtronic
- Abbott
- Pumps It, Inc.
- Embecta Corp
- Insulet Corporation
- Ypsomed AG
- Roche AG
- Tandem Diabetes Care, Inc.
- Terumo
- Novo Nordisk A/S
- SOOIL Developments Co., Ltd
- Microtec Medical Ltd
- ViCentra B.V.
- CeQur Corporation
- Dexcom, Inc.
Table of Contents
1. Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Diabetes Care Market, By Product Type
- Diabetes Care Market, By Diabetes Type
- Diabetes Care Market, By End User
- Diabetes Care Market, By Region
3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Impact Analysis
- Key Highlights
- Regulatory Scenario
- Product Launches/Approvals
- PEST Analysis
- PORTER's Analysis
- Merger and Acquisition Scenario
- Epidemiology
- Market Trends
4. Global Diabetes Care Market, By Product Type, 2019-2031, (USD Bn)
- Introduction
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2020 - 2031
- Segment Trends
- Glucose Monitoring Devices
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Blood glucose monitoring (BGM)
- Continuous glucose monitoring (CGM)
- Flash glucose monitoring (FGM)
- Insulin Pumps
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Patch pump
- Tethered pump
- Implanted insulin pump
- Others (Insulin Syringes, Pen Needles, etc.)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
5. Global Diabetes Care Market, By Diabetes Type, 2019-2031, (USD Bn)
- Introduction
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2020 - 2031
- Segment Trends
- Type 2 Diabetes
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Type 1 Diabetes
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Other (Gestational Diabetes, etc.)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
6. Global Diabetes Care Market, By End User, 2019-2031, (USD Bn)
- Introduction
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2020 - 2031
- Segment Trends
- Hospitals & Clinics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Homecare Settings
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Ambulatory Care Settings
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Others (Academic and Research Institutes, Clinical Laboratories, etc.)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
7. Global Diabetes Care Market, By Region, 2019 - 2031, Value (USD Bn)
- Introduction
- Market Share (%) Analysis, 2024,2027 & 2031, Value (USD Bn)
- Market Y-o-Y Growth Analysis (%), 2020 - 2031, Value (USD Bn)
- Regional Trends
- North America
- Introduction
- Market Size and Forecast, By Product Type, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Diabetes Type, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By End User, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Country, 2019 - 2031, Value (USD Bn)
- U.S.
- Canada
- Latin America
- Introduction
- Market Size and Forecast, By Product Type, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Diabetes Type, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By End User, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Country, 2019 - 2031, Value (USD Bn)
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Introduction
- Market Size and Forecast, By Product Type, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Diabetes Type, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By End User, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Country, 2019 - 2031, Value (USD Bn)
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- Introduction
- Market Size and Forecast, By Product Type, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Diabetes Type, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By End User, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Country, 2019 - 2031, Value (USD Bn)
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- Introduction
- Market Size and Forecast, By Product Type, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Diabetes Type, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By End User, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Country, 2019 - 2031, Value (USD Bn)
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- Introduction
- Market Size and Forecast, By Product Type, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Diabetes Type, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By End User, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Country/Region, 2019 - 2031, Value (USD Bn)
- South Africa
- North Africa
- Central Africa
8. Competitive Landscape
- Medtronic
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Abbott
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Pumps It, Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Embecta Corp
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Insulet Corporation
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Ypsomed AG
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Roche AG
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Tandem Diabetes Care, Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Terumo
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Novo Nordisk A/S
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- SOOIL Developments Co., Ltd
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Microtec Medical Ltd
- ViCentra B.V.
- CeQur Corporation
- Dexcom, Inc.
9. Analyst Recommendations
- Wheel of Fortune
- Analyst View
- Coherent Opportunity Map
10. References and Research Methodology
- References
- Research Methodology
- About us
